Ardmore, PA, United States of America

Elena Sotillo-Pineiro

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The Children's Hospital of Philadelphia. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elena Sotillo-Pineiro: Innovator in Cancer Treatment

Introduction

Elena Sotillo-Pineiro is a prominent inventor based in Ardmore, PA (US). She has made significant contributions to the field of cancer research, particularly in the treatment of B-cell lymphomas. Her innovative work focuses on enhancing therapeutic responses to chemotherapy.

Latest Patents

Elena holds a patent titled "Compositions and methods for transient up-regulation of Myc in B-cell lymphomas for enhancing P53 independent apoptotic responses to chemotherapy." This patent discloses compositions and methods that are useful for the treatment of cancer, specifically targeting lymphoma. Her research aims to improve the efficacy of chemotherapy by leveraging the Myc protein's role in cancer cell apoptosis.

Career Highlights

Elena is affiliated with The Children's Hospital of Philadelphia, where she conducts her research. Her work is instrumental in advancing the understanding of cancer treatment and developing new therapeutic strategies. She has dedicated her career to improving outcomes for patients suffering from lymphoma.

Collaborations

Elena collaborates with Andrei Thomas-Tikhonenko, a fellow researcher in the field. Their partnership enhances the scope and impact of their research efforts, contributing to the advancement of cancer treatment methodologies.

Conclusion

Elena Sotillo-Pineiro is a dedicated inventor whose work in cancer research is paving the way for innovative treatment options. Her contributions are vital in the ongoing battle against lymphoma, and her patent reflects her commitment to improving patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…